Atlas Trials

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission

Clinical trial NCT01817426 · COMPLETED

Trial details

NCT number
NCT01817426
Sponsor
Copenhagen University Hospital at Herlev
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Crohn Disease
Start date
2013-01-01
Primary completion
2020-05-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.